Liver fibrotic development is reduced through inflammation prevention by an adenosine derivative compound.
Dominguez-Lopez M; de Vaca RP; Rodriguez-Aguilera JR; Guerrero-Celis N; Velasco-Loyden G; de Sanchez VC (2023). Liver fibrotic development is reduced through inflammation prevention by an adenosine derivative compound. Biomed Pharmacother 165 :115216
ABSTRACT
Liver fibrosis is a global health problem, and studying its development provides important information to address its treatment. Here, we characterized the effects of an adenosine compound (IFC-305) on preventing fibrosis and liver inflammation.